Medication Prices Rise by 13% for Russians: Ukrainian Intelligence Reveals Details of Price Shock

In Russia, medication prices are rapidly rising, outpacing inflation rates by 3.5 times, reported the Ukrainian Foreign Intelligence Service.

From January to August 2025, the average price for a package of medication increased to 416 rubles, up 13.6% compared to the previous year. The most significant increases were noted for popular medications: ketorol increased by 30%, naftazoline by 25%, drotaverine (known as 'No-shpa') by 15%, corvalol by 14%, analgin and enalapril by 13%, and ibuprofen and citramon by 12%.

As a result, the consumption strategy for medications has changed: sales in packages decreased by 2.3%, but in monetary terms increased by 11% to 1.1 trillion rubles. Experts do not expect price reductions as the pharmacy market in Russia is controlled by three major networks, one of which is owned by the son-in-law of Russia's Foreign Minister Sergey Lavrov.

Consequently, the situation in the pharmaceutical sector in Russia reflects a systemic crisis, where medications are becoming less accessible to the population, and the market is turning into a monopoly linked to governmental structures.

In response to rising prices, State Duma deputies propose allowing Russians to buy pills individually rather than in full packages to save on treatment costs.

The increase in medication prices in Russia could lead to the population purchasing fewer medications due to their inaccessibility, which threatens the country's healthcare situation.